Summary
The relevance of the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds to the clinical therapeutics of acute myocardial infarction was evaluated in 20 patients with an uncomplicated acute myocardial infarction by comparing the haemodynamic effects of equivalent beta-blocking doses of propranolol (non-cardioselective; no ISA) and pindolol (non-cardioselective; 50% ISA). Consecutive eligible male patients admitted to a Coronary Care Unit were randomised following a 1 h control period to two separate studies. In Study 1 the short-term dose-response effects of propranolol (1–8 mg) or pindolol (0.1–0.8 mg) were assessed. In Study 2 comparison of the effects of single i.v. propranolol (8 mg) and pindolol (0.8 mg) doses was undertaken over 6 h. Haemodynamic variables and thermodilution cardiac output were subsequently recorded to compare the effects of each drug on the circulation. The plasma concentrations of propranolol and pindolol were in the recognised therapeutic range. Both drugs were clinically well-tolerated, the changes induced in haemodynamic variables following each drug demonstrated effective beta-blockade. Within the limits of the experimental protocol, these data did not suggest definite haemodynamic advantage for ISA of pindolol in acute myocardial infarction. These findings are perhaps due to sympathetic activation in acute myocardial infarction attenuating the haemodynamic impact of ISA.
Similar content being viewed by others
References
Sonnenblick EH, Ross J, Covell JW, Kaiser GA, Braunwald E (1965) Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol 209: 919–927
Braunwald E (1969) Thirteenth Bowditch Lecture. The determinants of myocardial oxygen consumption. Physiologist 12: 65–93
Opie LH, Thomas M (1976) Propranolol and experimental myocardial infarction. Postgrad Med J 52 [Suppl 4]: 124–134
Taylor SH, Burley D (1977) Beta-adrenoceptor drugs in post-myocardial infarction dysrhythmias. Proc Roy Soc Med 70 [Suppl 11]: 11–16
Singh BN and Jewett DE (1974) Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs 7: 426–461
Maroko PR, Kjekshus JK, Sobel BE et al. (1971) Factors influencing infarct size following experimental coronary artery occlusion. Circulation 43: 67–82
Norris RM, Clarke ED, Sammel NL, Smith WM, Williams B (1978) Protective effect of propranolol in threatened myocardial infarction. Lancet 2: 907–909
Pelides LJ, Reid DW, Thomas M, Shillingford JP (1972) Inhibition by beta-blockade of the ST segment elevation after acute myocardial infarction in man. Cardiovasc Res 6: 295–302
Reid DS, Pelides LJ, Shillingford JP, Thomas M (1976) Electrocardiographic surface mapping of the heart following myocardial infarction and the influence of beta-blockade. Postgrad Med J 52 [Suppl 4]: 135–139
Peter T, Norris RM, Clarke ED et al. (1978) Reduction of enzyme level by propranolol after acute myocardial infarction. Circulation 57: 1091–1095
Ramsdale D, Farragher BE, Ward C et al. (1982) Pain relief in acute myocardial infarction by intravenous atenolol. Am Heart J 103: 459–467
Svendsen TL, Hartling O, Trap-Jensen J (1979) Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89406 in healthy volunteers. Eur J Clin Pharmacol 15: 223–228
Svendsen T, Hartling OJ, Trap-Jensen J, McNair A, Bliddal J (1981) Adrenergic beta-receptor blockade: haemodynamic importance of intrinsic sympathomimetic activity. Clin Pharmacol Ther 29: 711–718
Taylor SH, Silke B, Lee PS (1981) Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity haemodynamically useful? N Engl J Med 306: 631–635
Taylor SH, Silke B, Lee PS, Hilail A (1982) Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease. Eur Heart J 3: 564–569
Karlsberg RP, Penkoske PA, Cryer PE, Corr PB, Roberts R (1979) Rapid activation of the sympathetic system following coronary artery occlusion: relation to infarct size, site and haemodynamic impact. Cardiovasc Res 13: 523–531
Valori C, Thomas M, Shillingford J (1967) Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol 20: 605–617
Kostuk W, Barr JW, Simon AL, Ross J (1973) Correlations between the chest film and haemodynamics in acute myocardial infarction. Circulation 48: 624–632
Carruthers SG (1982) Cardiac dose-response relationships of oral and intravenous pindolol. Br J Clin Pharmacol 13: 193S-198S
Dixon WJ, Brown MB (1979) Biomedical computer program — ‘P’ Series. University of California Press, Berkeley, pp 540–580
Winer BJ (1971) Statistical principles in experimental design (2nd edn). McGraw-Hill, New York, pp 197–200
Rose GA, Blackburn H (1968) Cardiovascular survey methods. WHO Monograph Series 56: 137–174
Lochan R, Silke B, Taylor SH (1981) Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous injection in man. Br J Clin Pharmacol 12: 721–724
Verma SP, Nelson GIC, Silke B, Hussain M, Taylor SH (1983) Are there any advantages of intravenous over oral beta-adrenoceptor blockade immediately following acute myocardial infarction (AMI). Clin Sci 65: 34p
Seino Y, Takano T, Tanaka K, Hayakawa H (1983) Peripheral circulatory adjustments and the vasodilator intervention in acute myocardial infarction. Abstracts VIII As-Pac Congr Cardiol, A-570
Ablad B, Carlsson E, Ek L, Johnsson G, Lundgren B (1979) General pharmacology of beta-adrenoceptor antagonists. In: Poppers PJ (ed) Beta-blockade and general anaesthesia. Astra Pharmaceuticals, Rijwijk, pp 46–58
Clark BJ, Menninger K, Bertholet A (1982) Pindolol — the pharmacology of a partial agonist. Br J Clin Pharmacol 13: 149S-158S
Silke B, Nelson GIC, Ahuja RC, Okoli RC, Taylor SH (1983) Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease. Eur J Clin Pharmacol 25: 157–165
Silke B, Nelson GIC, Ahuja RC, Taylor SH (1982) Comparative haemodynamic dose-response effects of propranolol and labetalol in coronary heart disease. Br Heart J 48: 364–371
Nelson GIC, Ahuja RC, Hussain M, Silke B, Taylor SH (1983) Alpha- and beta-blockade with labetalol in acute myocardial infarction. J Cardiovasc Pharmacol 4: 921–924
Silke B, Nelson GIC, Ahuja RC, Choudhury S, Taylor SH (1983) Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction. Ir J Med Sci 152: 179–186
Silke B, Nelson GIC, Verma SP, Hussain M, Walker C, Taylor SH (1984) Enhanced haemodynamic effects of propranolol in acute myocardial infarction. Eur Heart J 5: 366–373
Mueller H, Ayres SM (1976) Propranolol in acute myocardial infarction in man: effects on haemodynamics and myocardial oxygenation. Postgrad Med J 52 [Suppl 4]: 141–148
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silke, B., Verma, S.P., Ahuja, R.C. et al. Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?. Eur J Clin Pharmacol 27, 509–515 (1984). https://doi.org/10.1007/BF00556884
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00556884